能動植込み型医療機器市場：製品タイプ、インプラントタイプ、エンドユーザー別-2025-2030年の世界予測

能動植込み型医療機器市場は、2023年に26億5,000万米ドルと評価され、2024年には29億1,000万米ドルに達すると予測され、CAGR 9.92％で成長し、2030年には51億4,000万米ドルになると予測されています。

能動植込み型医療機器（AIMDs）とは、重篤な病状を管理するために、完全に、外科的に、あるいは医学的に人体に導入され、処置後もそこに留まることを目的とした器具を指します。ペースメーカー、除細動器、神経刺激装置、人工内耳のような機器を含みます。これらの機器は、症状を緩和したり身体機能を回復させたりすることで、慢性疾患の患者にとって極めて重要です。心血管疾患、神経疾患、聴覚障害の有病率の増加は、市場需要の主な促進要因です。さらに、ヘルスケア支出の増加、医療技術の進歩、高齢化も市場拡大に大きく寄与しています。小型化、ワイヤレス技術、生体適合性の向上など、現在の技術革新は有望な機会をもたらしています。企業には研究開発への投資が奨励され、電池寿命の向上や感染リスクの低減を実現した多機能機器の開発に注力しています。こうした楽観的な見方にもかかわらず、厳しい規制要件、高い市場開拓コスト、機器の不具合から生じる合併症といった課題が、市場の成長を制限しています。このような障害を軽減するためには、コンプライアンスとリスク管理の枠組みを真摯に構築することが不可欠です。さらに、各国の複雑な償還制度が市場の緊張を高めています。しかし、遠隔医療統合や遠隔モニタリング機能などのデジタル・ヘルス・アプリケーションを取り入れることで、ビジネスに大きなメリットをもたらすことができます。さらに、遺伝子プロファイルや特定の患者のニーズに基づいて機器をカスタマイズする個別化医療の探求にも可能性があります。新興市場は、ヘルスケアのインフラが未整備で、多くの患者プールが存在するため、未開拓のビジネスチャンスがあります。ヘルスケアプロバイダーと戦略的パートナーシップを結び、AIMDに関する教育イニシアチブに注力することで、市場浸透を促進することもできます。要するに、AIMD市場は技術革新、適応力、戦略的パートナーシップの適切な組み合わせによって成長の機が熟しているといえるが、規制や財政上の制約を慎重に乗り越える必要があります。

市場力学：急速に進化する能動植込み型医療機器市場の主要市場インサイトを公開

能動植込み型医療機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患の有病率の上昇
  • 神経疾患患者の増加
  • 神経刺激装置の認知度向上と普及
• 市場抑制要因
  • 植え込み型医療機器に伴う健康への悪影響
• 市場機会
  • 次世代IMDにおけるコンピューティングと通信機能の統合
  • 先端医療機器分野における研究開発投資の急増
• 市場の課題
  • 認可のための高コストと厳しい規制に対する懸念

ポーターのファイブフォース：能動植込み型医療機器市場をナビゲートする戦略ツール

ポーターのファイブフォース」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：能動植込み型医療機器市場における外部からの影響の把握

外部マクロ環境要因は、能動植込み型医療機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析能動植込み型医療機器市場における競合情勢の把握

能動植込み型医療機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス能動植込み型医療機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、能動植込み型医療機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨能動植込み型医療機器市場における成功への道筋を描く

能動植込み型医療機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の罹患率の上昇
    • 神経疾患患者の増加
    • 神経刺激装置の認知度と採用の増加
  • 抑制要因
    • 埋め込み型医療機器による健康への悪影響
  • 機会
    • 次世代IMDにおけるコンピューティングと通信機能の統合
    • 先端医療機器分野における研究開発投資の急増
  • 課題
    • 高額な費用と厳しい認可規制への懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 能動植込み型医療機器市場：製品別

• 人工内耳
• 血行動態サポート
• 埋め込み型心臓ペースメーカー
• 植込み型除細動器
• 埋め込み型血糖モニター
• 埋め込み型輸液ポンプと付属品
• 埋め込み型モニタリングデバイス
• 埋め込み型神経刺激システム
• 補助人工心臓

第7章 能動植込み型医療機器市場インプラントの種類別

• 完全なインプラント
• 部分埋め込み型

第8章 能動植込み型医療機器市場：エンドユーザー別

• 外来センター
• 心臓センター
• 歯科医院
• 病院

第9章 南北アメリカの能動植込み型医療機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の能動植込み型医療機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの能動植込み型医療機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Abbott Laboratories
• Aleva Neurotherapeutics
• Allergan Inc. by AbbVie Inc.
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Cochlear Ltd.
• CONMED Corporation
• Definitive Healthcare, LLC
• Demant A/S
• Dentsply Sirona Inc.
• Globus Medical, Inc.
• GMED
• Integra Lifesciences Holdings Corporation
• Invibio Ltd.
• Johnson & Johnson Services, Inc.
• LivaNova PLC
• Medtronic PLC
• Microport Scientific Corporation
• NuVasive, Inc.
• Smith & Nephew PLC
• Sonova Holding AG
• Straumann AG
• Stryker Corporation
• TUV Rheinland AG
• Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
• Zimmer Biomet

LIST OF FIGURES

• FIGURE 1. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HAEMODYNAMIC SUPPORT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE CARDIAC PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANTABLE NEURO STIMULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COMPLETE IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PARTIAL IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. ITALY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. POLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. POLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. POLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. QATAR ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. QATAR ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. QATAR ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY IMPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 153. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Active Implantable Medical Devices Market was valued at USD 2.65 billion in 2023, expected to reach USD 2.91 billion in 2024, and is projected to grow at a CAGR of 9.92%, to USD 5.14 billion by 2030.

Active Implantable Medical Devices (AIMDs) refer to instruments intended to be introduced fully, surgically, or medically into the human body, and stay there post-procedure, to manage severe medical conditions. They encompass devices like pacemakers, defibrillators, neurostimulators, and cochlear implants. These devices are crucial for patients with chronic conditions by alleviating symptoms or restoring bodily functions. The growing prevalence of cardiovascular diseases, neurological disorders, and hearing impairments are key drivers of market demand. Additionally, increasing healthcare spending, advancements in medical technologies, and aging populations contribute significantly to market expansion. Current innovations, such as miniaturization, wireless technologies, and improved biocompatibility, present promising opportunities. Companies are encouraged to invest in R&D, focusing on creating multifunctional devices with enhanced battery life and reduced risk of infection. Despite the optimism, challenges such as stringent regulatory requirements, high costs of development, and complications arising from device failure limit market growth. The necessity for diligent compliance and risk management frameworks is crucial to mitigate such hindrances. The complex reimbursement landscapes in different countries further add to market strain. However, embracing digital health applications, such as telemedicine integration and remote monitoring capabilities, can provide significant business advantages. Furthermore, there is potential in exploring personalized medicine to customize devices based on genetic profiles and specific patient needs. Emerging markets present untapped opportunities due to inadequate healthcare infrastructure and the availability of a large patient pool. Engaging in strategic partnerships with healthcare providers and focusing on educational initiatives about AIMDs can also boost market penetration. In essence, the AIMD market is ripe for growth with the right blend of innovation, adaptability, and strategic partnerships, although careful navigation of regulatory and financial constraints is necessary.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Active Implantable Medical Devices Market

The Active Implantable Medical Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cardiovascular diseases
  • Growing number of patients with neurological disorders
  • Increase in awareness and adoption of neurostimulator devices
• Market Restraints
  • Associated adverse health impacts of implantable medical devices
• Market Opportunities
  • Integration of computing and communication capabilities in next generation IMDs
  • Surging R&D investment in field of advanced medical devices
• Market Challenges
  • Concern regarding high cost and stringent regulations for approval

Porter's Five Forces: A Strategic Tool for Navigating the Active Implantable Medical Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Active Implantable Medical Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Active Implantable Medical Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Active Implantable Medical Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Active Implantable Medical Devices Market

A detailed market share analysis in the Active Implantable Medical Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Active Implantable Medical Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Active Implantable Medical Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Active Implantable Medical Devices Market

A strategic analysis of the Active Implantable Medical Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Active Implantable Medical Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Aleva Neurotherapeutics, Allergan Inc. by AbbVie Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cochlear Ltd., CONMED Corporation, Definitive Healthcare, LLC, Demant A/S, Dentsply Sirona Inc., Globus Medical, Inc., GMED, Integra Lifesciences Holdings Corporation, Invibio Ltd., Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, NuVasive, Inc., Smith & Nephew PLC, Sonova Holding AG, Straumann AG, Stryker Corporation, TUV Rheinland AG, Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd., and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Active Implantable Medical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cochlear Implants, Haemodynamic Support, Implantable Cardiac Pacemakers, Implantable Defibrillators, Implantable Glucose Monitors, Implantable Infusion Pumps & Accessories, Implantable Monitoring Devices, Implantable Neuro Stimulator Systems, and Ventricular Assist Devices.
• Based on Implant Type, market is studied across Complete implantable and Partial implantable.
• Based on End-User, market is studied across Ambulatory Centers, Cardiac Centers, Dental Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cardiovascular diseases
    • 5.1.1.2. Growing number of patients with neurological disorders
    • 5.1.1.3. Increase in awareness and adoption of neurostimulator devices
  • 5.1.2. Restraints
    • 5.1.2.1. Associated adverse health impacts of implantable medical devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of computing and communication capabilities in next generation IMDs
    • 5.1.3.2. Surging R&D investment in field of advanced medical devices
  • 5.1.4. Challenges
    • 5.1.4.1. Concern regarding high cost and stringent regulations for approval
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Active Implantable Medical Devices Market, by Product

• 6.1. Introduction
• 6.2. Cochlear Implants
• 6.3. Haemodynamic Support
• 6.4. Implantable Cardiac Pacemakers
• 6.5. Implantable Defibrillators
• 6.6. Implantable Glucose Monitors
• 6.7. Implantable Infusion Pumps & Accessories
• 6.8. Implantable Monitoring Devices
• 6.9. Implantable Neuro Stimulator Systems
• 6.10. Ventricular Assist Devices

7. Active Implantable Medical Devices Market, by Implant Type

• 7.1. Introduction
• 7.2. Complete implantable
• 7.3. Partial implantable

8. Active Implantable Medical Devices Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Centers
• 8.3. Cardiac Centers
• 8.4. Dental Clinics
• 8.5. Hospitals

9. Americas Active Implantable Medical Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Active Implantable Medical Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Active Implantable Medical Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Abbott Laboratories
• 3. Aleva Neurotherapeutics
• 4. Allergan Inc. by AbbVie Inc.
• 5. BIOTRONIK SE & Co. KG
• 6. Boston Scientific Corporation
• 7. Cochlear Ltd.
• 8. CONMED Corporation
• 9. Definitive Healthcare, LLC
• 10. Demant A/S
• 11. Dentsply Sirona Inc.
• 12. Globus Medical, Inc.
• 13. GMED
• 14. Integra Lifesciences Holdings Corporation
• 15. Invibio Ltd.
• 16. Johnson & Johnson Services, Inc.
• 17. LivaNova PLC
• 18. Medtronic PLC
• 19. Microport Scientific Corporation
• 20. NuVasive, Inc.
• 21. Smith & Nephew PLC
• 22. Sonova Holding AG
• 23. Straumann AG
• 24. Stryker Corporation
• 25. TUV Rheinland AG
• 26. Zhejiang Nuoerkang Neuroelectronic Technology Co., Ltd.
• 27. Zimmer Biomet